Aim: This study focuses on the documentation and critical evaluation of the presence of botanical nootropics in Ayurveda based on the available classical literature in Ayurveda. The study also entails the terminology used for different memory and cognitive functions in the classical texts of Ayurveda.
Ayurveda, Medha or intelligence of an individual depends upon the correlation of different biological, genetic, environmental, and dietetic factors, such as jaati (race), prakriti (inherent morphological, physiological, and psychological attributes of individual), abhyaasa (practice), aahaara (food), swarupa (configuration of the skull and brain), etc. Capacity to recollect the past is called smriti or memory (smriti bhutaardha vijnaanam). 8 The mental registration of past experience, knowledge, ideas, sensations, and thoughts is called memory. 8 Registration of experience is favored by clear comprehension during intense consciousness, but it may occur during catatonic stupor (mattavastha). Retention of memory differs greatly with individuals as well as with structural and psychological variations. Memory recall means its intentional recollection and reproduction in consciousness, while clear comprehension greatly favors retention.
Recall may fail because the memory has been obliterated or functionally became the stream of ideas that one does not want to remember. Prasstapaada in his commentary on "Vaisheshik darshana" defines smriti as union or coordinated function of soul (aatma) and mind (manas). According to his text, seeing, hearing, or experiencing anything evokes the past incidence. However, memory depends on one's desire to recollect (Ichcha) and effort to recollect (anusmarana). 9 Cognition is the mental action or process of acquiring knowledge and understanding through thought, experience, and the senses. It encompasses processes, such as knowledge, attention, memory and working memory, judgment and evaluation, reasoning and computation, problem-solving and decision-making, comprehension and production of language, etc. Ayurvedic texts, viz. Bhela Samhita and Astang hridya, clearly stand for the above process of cognition and attributed to the functions of biological factors, viz. buddhi vaishesika aalochakapitta, and sadhak pitta 10 (Table 1) .
Safe and Effective Pharmacological Approaches for Neurocognitive Enhancement: Need of the Hour
The most commonly used class of drug is stimulants, such as caffeine for cognitive enhancement, which are used primarily to treat cognitive or motor function difficulties attributable to disorders, such as Alzheimer's disease, Parkinson's disease, and Huntington's disease. 12 Certain studies reported common use of these agents despite concern for further research. Scientific studies support the beneficial effects of some compounds. Several factors positively and negatively influence the use of drugs to increase cognitive performance. 12 Considering the limitation of certain synthetic agents, it is imperative to develop safe and effective agents preferably from plant source. Ayurveda enumerates a number of such medicinal plants for neurocognitive enhancement. In spite of great advancement in the science of psychiatry for decades, the problems with the management of a certain mental problems like cognitive dysfunction, memory disorders, anxiety, stress, mental retardation, etc., have remained unsolved. In addition, adverse effects of antipsychotic medication are creating considerable amount of discomfort to the patient. At this juncture, there is a need for exposition and adaptation of such therapies that could effectively tackle such conditions without any adverse events. The entire Ayurvedic management is more health-oriented than disease-oriented, and as such, there is a big scope of utilizing Ayurvedic approach and therapeutics as an adjunct to the diseaseoriented therapy of modern psychiatry to provide a full treatment. Various treatment modalities are described in the Ayurvedic classics which include the following.
Botanical Nootropics in Ayurveda
Daiv Vyapashraya: Spiritual therapy that includes the use of prayers, religious activities, wearing of precious stones, etc.
Satvavjaya: Psychobehavioral therapy incorporating the principles of assurance therapy (aashvasan), replacement of emotions, and psychoshock therapy.
Yukti Vypashraya Chikitsa: Pharmacological therapy includes samshodhan (cleansing therapy/panchkarma) and shaman therapy (pacification). The patient is subjected to biocleansing therapy in order to cleanse the channels (Cont'd…) JDRAS of the body followed by shaman therapy or palliative treatment with the help of drug, dietetics, and lifestyle. A number of single and compound medhya (promoters of intellectual faculties) formulations are used in Ayurveda for the treatment of mental diseases. These are believed to act as brain tonics and adaptogens. The medhya drugs are considered as specific molecular nutrients for the brain providing a better mental health, leading in turn to alleviation of behavioral alterations.
Overview of Some Research Contributions
The
Manas Mandata (mental retardation), chittodvega (anxiety neurosis). 22 
Manas Mandata (Mental Retardation)
• A double-blind study was conducted with Mandukparni (Centella asiatica L. Urb.) whole plant on 30 mentally retarded children in the age group of 7 to 18 years. Children with a history of epilepsy and other neurological problems were excluded. The children were assessed on Binet-Kamat test and on a behavioral schedule. Children were given 0.5 gm tablets twice a day for 6 months. Placebo group was given starch tablet. All the children were reassessed after 3 and 6 months. The results indicated that there is an improvement in the intelligence quotient (IQ) level of the children treated with Mandukparni as compared with placebo, and the data were found to be significant at the end of 3 months; however, it was observed that there was no significant difference in improvement in the IQ level after 3 and 6 months. 23 • The Council has formulated Ayushman-8 for the treatment of Manas Mandata (mental retardation). The preparation of Ayushman-8 consists of (i) Brahmi (C. asiatica L. Urb.); (ii) Shankhapushpi (Convolvulus pluricaulis Choisy); (iii) Vacha (Acorus calamus L.) in different ratios. The evaluation was carried out on 51 confirmed cases of Manas Mandata in the age group of 5 to 16 years. They were classified into study group and placebo group. Study group was given Ayushman-8, at the dose of 700 mg twice a day with honey, whereas placebo group 700 mg of plain sugar for 1 year. Out of 51 children enrolled, 26 patients were put under study group and 25 in placebo group, 12 children left the study (7 in trial group and 5 in placebo group), and rest completed 1-year duration. Results showed that there was numerical increase in the mental age in both the groups. However, the increase shown by the drug was greater than that of placebo.
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Unmada (Schizophrenia)
• Brahmyadiyoga, a herbal compound consisting of fine 108 patients who completed the treatment for a period of 2 months were taken for final assessment. The route of administration was oral, 2 gm four times a day, i.e., Tagar, Brahmyadi Yoga, placebo and 50 mg chlorpromazine four times a day dose of the medicine given for the first month. The dose of medicine was increased to 3 gm four times a day in the case of first three groups and 75 mg four times a day in the case of chlorpromazine group. Results of four treatments were compared simultaneously for their mean improvement in the mental states by analysis of variance. The results showed that chlorpromazine was found to be superior to Tagara and placebo. However, overall effect of chlorpromazine was found to be better than Brahmyadi Yoga but difference is not statistically significant. It was observed that improvement in mental condition of patient treated with Brahmyadi Yoga was found to be significantly more than that obtained with single drug Tagara and placebo. 25 Another study with 36 patients of both the genders in the age group of 16 to 45 years suffering from Schizophrenia with active psychotic symptoms of a minimum duration of 1 month was conducted. Patients suffering from epilepsy or mental retardation were excluded. Out of 36 patients, 18 were managed on Ayurvedic line and the other 18 patients were given chlorpromazine therapy. In Ayurvedic treatment, it was intended to examine the combined effect of the general line of Ayurvedic treatment, comprising Shodhana, Shamana, and Satvavajaya Chikitsa followed by medicinal therapy; Kalyanakaghrita in case of Vataja, Pittaja Unmada, and Panchgavyghrita in Kaphja unmada 10 mL once a day. Results revealed that the scheduled Ayurvedic regimen is effective in 85% of cases of Unmada. This suggested that the Ayurvedic treatment is efficacious comparable to standard drug chlorpromazine. 26 
Chittodvega (Anxiety neurosis)
• A pilot study on 10 patients of either sex suffering from uncomplicated anxiety neurosis (Chittodvega) of 6 months chronicity was conducted with Kshirodhara (pouring of milk on forehead) in supine position. Assessment was done based on the Max Hamilton's Anxiety Rating Scale, Manifest Anxiety Scale and Symptoms. Results revealed that 8 patients showed clinically significant improvement. 27 
Evidence Based and Scientific Studies on Some Botanical Nootropics
Though several plants have been used as nootropic, here we describe some of the well-known plants.
Experimental and clinical studies have demonstrated efficacy, mode of action of some medicinal plants mentioned in Ayurvedic text for their nootropic and neurocognitive enhancing effects, and brief description on five most important plants.
Mandukparni (C. asiatica L. Urb.)
The utilization of this herb in the central nervous system (CNS)-related disorders is evident from the appearance of this herb in the ancient Ayurvedic texts. The herb is used in different purposes, such as a memory enhancer, immune booster, strength promoting, antiepileptic, antianxiety, and adaptogen. 28, 29 The aqueous extracts of C. asiatica were evaluated in intracerebroventricular streptozotocin-induced cognitive impairment and oxidative stress in rats, and it was found that the plant possessed cognitive-enhancing effect and also an involvement of antioxidant mechanism. 30 The use of this plant is also found clinically for the anxiety neurosis and for mentally retarded children 23 as well and showed improvement in the short-term memory and learning abilities in both animal models and humans. 23, 31 The plant is also utilized in the traditional eastern cultures as sedative, which was assumed due to its phytoconstituents brahmoside and brahminoside. The plant also possesses anxiolytic properties which are associated due to binding to cholecystokinin receptors, which are G protein coupled-type receptors and bind the peptide hormones cholecystokinin or gastrin and were considered to play a significant role in modulation of anxiety, memory, and hunger and nociception in animals and humans. 29, 32 The herb is also known to invigorate the nervous system and brain and increase concentration, attention span, and combat aging.
32,34
Brahmi, Bacopa monnieri (L.) Wettst
Bacopa monnieri (L.) Wettst is used in traditional medicine for the treatment of various nervous disorders, for the enhancement of memory development, concentration, and learning performance. It is also useful for the anxiety and several other therapeutic purposes. 35, 36 There are a large number of phytoconstituents that have been reported from Bacopa monnieri, which include alkaloid brahmine, herpestine, bacosides A[3-(α-L-arabinopyranosyl)-O-β-D-glucopyranoside-10,20-dihydroxy-16-keto-dammar-24-ene], nicotine; triterpenoid saponins, saponins A, B, and C, β-sitosterol, stigmastanol, D-mannitol, betulinic acid, and pseudojujubogenin glycoside. 8, [37] [38] [39] [40] [41] A number of behavioral studies in animals have been carried out, including the antidepressant studies that showed Bacopa improved learning of motor functions, acquisition and retention, and delay extinction of newly acquired behavior.
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Jyotishmati, Celastrus paniculatus Willd. (CP)
Jyotishmati botanically identified as Celastrus paniculatus Willd. (CP) belongs to family Celastraceae. 44 The seed oil of the plant was reported to have sedative action in rats; however, no such effects were recorded when tested in rabbits. The seed oil was also found to have some tranquilizing effect on adrenaline and amphetamine-induced excitement when tested in mice.
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JDRAS
Shankhpushpi, Convolvulus pluricaulis Choisy (Syn. Convolvulus prostratus Forssk.)
This is one of the most popular plants used in various CNS-related disorders in different traditional medicine systems. The plant is used for the treatment of insomnia, fatigue, nervous debility, low energy level, and also as brain tonic. The plant is well recognized as a memory enhancer and is used as a psychostimulant and reduces mental tension as well. 46 The plant was studied in different in vitro and in vivo models for its various neuroprotective effects. Researchers from the India and USA investigated the potential of Convolvulus pluricaulis aqueous extract to attenuate scopolamine-induced amplified protein and messenger ribonucleic acid levels of tau, amyloid precursor protein, amyloid β levels, which are the biomarkers for Alzheimer's diseases. The extract reduced the biomarkers and also improved the histological changes that occur in Alzheimer's disease in rat brain. 47 The plant was also reported for the enhancement of memory as well as improvement in cognitive function in several behavioral studies and also found to reduce the plasma cortisol and urinary catecholamine levels in clinical study.
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Vacha, Acorus calamus L.
In Atharva Veda (3000 BC), Vacha was used in the prashana karma and as an amulet to be worn in kantha pradesha for well-being of a person (A.P.I/44/10, 5/1/5). Sayana explained that this drug improves the intelligence and speech of an individual (2/7/10-13). It was used as a krimihara and sanjyasthapaka dravya (2/31/2-5 51, 52 Treatment of 50 cases of depression with A. calamus (500 mg in dose of two tablets three times a day) for 6 weeks showed reduction in the degree of severity of depression and better rehabilitation and also a significant improvement in assessment based on the rating of symptoms on the Hamilton Depression Rating Scale.
50,53
CONCLUSION
Mental health is one among the important health concerns in the emerging scenario, owing to the paradigm shift of the disease burden from communicable disease to noncommunicable disease in developed and developing countries. Attributable to the lifestyle changes, utmost importance has been given to prevention of mental disorders besides promotion of mental health and management of psychiatric illness in Ayurveda. The causal relationship between the mind and its role in the causation of physical illness is clearly dealt in Ayurveda and other nonmedical literatures indigenous to India, which has been recently recognized by the modern world. Several lifestyle interventions (Sadvrita) and pharmacological interventions comprising single drugs and compound formulations have been vividly described for the management of disorders.
In view of the alarming increase of mental illness in recent times and unmet medical needs in the field of psychiatry, there is need felt to explore suitable safe and effective options and modalities from plant resources. With the rich background of Ayurveda literature embodied with enormous botanical resources attributed with diversified actions and potentials to combat psychotic illness and also promotion of mental health, the drug development process may be taken forward adopting Ayurveda approach or phytopharmaceutical approach suitably satisfying the requisite formalities to ensure quality, safety, and efficacy as deemed.
Considering the limitations of conventional management, need is felt to mainstream the Ayurvedic approaches with rich background and potential in the management of psychiatric illness that could affectively cater the unmet needs in this field. The potential leads from Ayurveda texts may be taken forward for further development of safe, effective, and user-friendly dosage forms through systematic preclinical and clinical studies.
